Scientists pivot to COVID-19 research, hoping for quick results to deal with pandemic

coronavirus computer graphic

Professors Patrick Hsu and Niren Murthy are featured with the emergency funding they have received for urgent COVID-19 research. Hsu is working to apply new CRISPR tools he has discovered to a faster and better diagnosis of COVID-19 infection and potentially new therapeutics, while Murthy is looking for weaknesses in the SARS-CoV-2 proteins that could be leveraged by a small molecule, hopefully knocking out the virus.

Read More

Patrick Hsu on COVID-19 test reliability in the NYTimes

photo of Hsu by Chris Keeney

Prof. Hsu is one of the leaders of a round-the-clock effort to validate the accuracy of 14 of the many COVID-19 antibody test kits now on the market. Although the results are promising, they are also complex and show much room for improvement, especially in the area of false positives. The team will continue to validate the increasing variety of tests to inform medical testing procedures. Their pre-publish results are available online.

Read More